CUV clinuvel pharmaceuticals limited

Ann: Notification of buy-back - CUV, page-6

  1. 2,516 Posts.
    lightbulb Created with Sketch. 686
    I am wondering this myself too. Why bother announcing a buyback if they had no intention of doing it.

    Market cap is now below $500m. Subtract the cash which is $183m (but probably higher now) that leaves $317m valuation on the existing business which is growing at a steady pace. Less than 8 times forward NPAT if you think they can grow at a similar pace (to roughly 40m NPAT) with zero value on anything outside their existing income streams.

    In that situation what could they possibly want to do with $180-200m cash that they couldn't do with $150m~ cash if they went through with the buyback? It doesn't exactly limit their options.


    Last edited by htae39: 03/06/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$9.76
Change
-0.050(0.51%)
Mkt cap ! $493.7M
Open High Low Value Volume
$9.90 $10.00 $9.76 $618.8K 62.64K

Buyers (Bids)

No. Vol. Price($)
1 195 $9.76
 

Sellers (Offers)

Price($) Vol. No.
$9.89 351 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.